newsfilter
← Latest News
GlobeNewswire·

Spyre Therapeutics to Participate in Upcoming June Investor Conferences

WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of